Drug intelligence / Profile preview

resusix

Development stage
Phase 1
Lead developer
Entegrion
Modality
Tissue Cells → Other Cell Types → Cell Therapies, Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Resusix is a portable, shelf-stable blood product derived from pooled human plasma that has undergone solvent/detergent (S/D) pathogen inactivation and spray drying. It is designed as a resuscitation fluid for use in trauma patients experiencing severe blood loss, particularly in remote or austere environments where traditional fresh frozen plasma (FFP) is impractical due to cold chain requirements. The product maintains functional clotting capability and aims to promote systemic vascular stability while preventing coagulopathy and inflammation. Resusix offers an extended shelf life of over two years and can be rehydrated for infusion when needed. It provides a safer alternative to FFP by being free of micro particles and cell fragments commonly found in FFP[1][3][4][5][6][7].

Brand names
Resusix
Other names
virus inactivated dried plasmaspray-dried solvent/detergent-treated plasmaspray dried pooled plasma

Beyond the preview

Go deeper on resusix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on resusix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call